“…Here, we explore the potential mechanisms contributing to the sex-biased prevalence disparity in ASD using various preclinical models (Table 1). While preclinical rodent models of ASD cannot fully replicate the spectrum of human ASD phenotypes [8], potentially due to differences in brain structures and developmental trajectories [9], they remain invaluable for gaining mechanistic Chd8 +/N2373K Sexually dimorphic changes in neuronal activity, synaptic transmission, and transcriptomic profiles [40] Fmr1 KO Sexually dimorphic upregulation of ASD risk genes (male↑: Ctnnb1 a and Grin1 a , female↑: Homer1 a , Ptgs2 a , Drd1 a , Pik3ca b , and Csnk1g1 b ) [44] Microglial abnormalities Cntnap2 KO Activated morphology and phagocytosis of synaptic structures in male microglia [58] DEP/MS Hyper-ramified phenotype in male microglia [63] Hormones VPA-induced ASD mouse model Lower levels of TH expression in the AVPV of male mice [70] Placenta-specific Akr1c14 KO Male mouse-specific abnormalities in cerebellar white matter [75] Escape from X chromosome inactivation Prenatal stress model Placental OGT expression levels are twice as high for female fetuses as for male fetuses; this results in sexually distinct gene expression in trophoblasts through epigenetic modulation by histone methylation [79,80] Integrated stress response pathway MIA (Poly[I:C]) Hyperactivation of the ISR pathway in male MIA offspring, resulting in reduced nascent protein synthesis in the brain [85] Immune pathways Prenatal GBS infection Heightened levels of pro-inflammatory cytokines and chemokines such as IL-1β and CINC-1/CXCL1 in male fetuses [98] MIA (LPS) Male MIA offspring exhibit heightened cortical hypoxia, reduced mitosis of radial glial cells, disrupted E/I balance within the brain, severe placental necrosis, elevated inflammation, and reduced placental growth [99] MIA (two-hit model) The anti-inflammatory cytokines IL-10 and TGF-β1 are decreased in male offspring but increased in female mice [100] ↑: upregulated, a : high-confidence risk genes for ASD, b : suggestive risk genes for ASD. ASD, autism spectrum disorder; Shank3, SH3 and multiple ankyrin repeat domains 3; KO, knockout; mGluR5, metabotropic glutamate receptor 5; Chd8, chromodomain helicase DNA-binding protein 8; Fmr1, fragile X mental retardation 1; Ctnnb1, catenin beta 1; Grin1, glutamate ionotropic receptor NMDA type subunit 1; Homer1 , homer scaffold protein 1; Ptgs2 , prostaglandin-endoperoxide synthase 2; Drd1 , dopamine receptor D1; Pik3ca , phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; Csnk1g1, casein kinase 1 gamma 1; Cntnap2, contactin-associated protein 2; DEP/MS, diesel exhaust particles and maternal stress; VPA, valproic acid; TH, tyrosine hydroxylase; AVPV, anteroventral periventricular nucleus; Akr1c14 , aldo-keto reductase family 1 member C4; OGT, O-linked-N-acetylglucosamine transferase; MIA, maternal immune activation; poly(I:C), polyinosinic:polycytidylic...…”